Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Therapeutic Efficacy of Intravenous Prostaglandin E1 Versus Pentoxifylline in Patients with Intermittent Claudication

  • Conference paper
Prostaglandin E1

Abstract

As a rule, walking training is undoubtedly the treatment of choice for patients with arterial occlusive disease at the intermittent claudication stage (stage IIb). The adaptation of the cardiovascular and nervous system and of skeletal muscle induced by walking training increases the endurance of these patients [3]. Drug treatment is considered for patients who are not suitable candidates for, or who do not show an adequate response to, programmed exercising.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blume J (1987) Klinische Wirksamkeit der intraarteriellen Infusionstherapie mit Prostaglandin E! im Stadium lib der arteriellen VerschluBkrankheit. Therapiewoche 37: 4819–4823

    Google Scholar 

  2. Böhme H, Brülisauer M, Härtel U, Bollinger A (1989) Periphere arterielle VerschluBkrankheit im Stadium III und IV - kontrollierte Zweizentren-Studie zur Wirksamkeit von intraarteriellen Prostaglandin-E1-Infusionen. Med Welt 40: 1501–1503

    Google Scholar 

  3. Cachovan M, de Marées H, Kunitsch G (1976) Einfluß von Intervalltraining auf die Leistungsfähigkeit und periphere Durchblutung bei Patienten mit Claudicatio intermittens. Z Kardiol 65: 54–59

    CAS  Google Scholar 

  4. Creutzig A, Caspary L, Radeke U, Specht S, Ranke C, Alexander K (1988) Prospektive randomisierte Doppelblindstudie zur Wirksamkeit von i. a. Prostaglandin E1 bei der schweren Claudicatio intermittens. In: Heidrich H, Böhme H, Rogatti W (eds) Prostaglandin E1- Wirkungen und therapeutische Wirksamkeit. Springer, Berlin Heidelberg New York, pp 95–102

    Google Scholar 

  5. Dé P, Hepp W (1990) Erfahrungen mit i. v. Prostaglandin E1 bei arterieller Verschlußkrankheit im Stadium IIb. Vasa 30 [Suppl]: 139–141

    Google Scholar 

  6. Diehm C, Kühn A, Strauss R, Hübsch-Müller C, Kübler W (1989) Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication. Vasa 28 [Suppl]: 26–30

    CAS  Google Scholar 

  7. Gruß JD, Vargas-Montano H, Bartels D, Simmenroth HW, Sakurai T, Schäfer G, Fietze-Fischer B (1984) Use of prostaglandins in arterial occlusive diseases. Int Angiol 3 [Suppl]: 7–17

    Google Scholar 

  8. Heidrich H (1985) Vasoaktive Pharmaka bei peripheren arteriellen Durchblutungsstörungen. Dtsch Med Wochenschr 110: 1219–1224

    Article  PubMed  CAS  Google Scholar 

  9. Heidrich H, Ranft J, Peters A, Rummel S (1987) Früh- und Spätergebnisse nach intravenöser Prostavasin-Therapie bei peripher-arteriellen Durchblutungsstörungen mit Ruheschmerz und Nekrose. Vasa 20 [Suppl]: 202–203

    Google Scholar 

  10. Rudofsky G (1988) Intravenöse PGE1-Infusionsbehandlung bei Patienten mit arterieller Verschlußkrankheit im Stadium IIb. In: Heidrich H, Bohme H, Rogatti W (eds) Prostaglandin E1- Wirkungen und therapeutische Wirksamkeit. Springer, Berlin Heidelberg New York, pp 103–111

    Google Scholar 

  11. Rudofsky G, Altenhoff B, Meyer P, Lohmann A (1987) Intra-arterial perfusion with prostaglandin Et in patients with intermittent claudication. Vasa 17 [Suppl]: 47–51

    CAS  Google Scholar 

  12. Scheffler P, de la Hamette D, Leipnitz G (1989) Therapeutic efficacy of intravenously applied prostaglandin E1. Vasa 28 [Suppl]: 19–25

    CAS  Google Scholar 

  13. Trübestein G, v Bary S, Breddin K, Diehm C, Gruß JD, Heinrich H, Horsch S, Kriessmann A, Maass U, Martin M, Maurin N, Scheffler P (1989) Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease - a controlled randomised multicenter study. Vasa 28 [Suppl]: 44–49

    Google Scholar 

Download references

Authors
  1. W. Hepp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. von Bary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Corovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Diehm
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Mühe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Rudofsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Scheffler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Trübestein
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Vogelpohl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Med. Klinik im Rehabilitationskrankenhaus Karlsbad, D-7516, Karlsbad, Germany

    Curt Diehm

  2. Wilhelm-Auerswald-Atheroskleroseforschungsgruppe Wien, Nadlergasse 1, A-1090, Wien, Germany

    Helmut Sinzinger

  3. Nerthusstraße 3a, D-5000, Köln 91, Germany

    Waltraud Rogatti

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hepp, W. et al. (1991). Therapeutic Efficacy of Intravenous Prostaglandin E1 Versus Pentoxifylline in Patients with Intermittent Claudication. In: Diehm, C., Sinzinger, H., Rogatti, W. (eds) Prostaglandin E1 . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76910-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76910-8_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54524-8

  • Online ISBN: 978-3-642-76910-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation